Stockton Road Capital has bought a minority stake together with CCMP Capital Advisors Llc affiliates in their purchase of Jamieson Laboratories. Financial terms of the acquisition were not disclosed. Information from its website revealed that Stockton Road Capital is a specialized private equity investment firm and advisor whose focus is on consumer products businesses that have revenues over $10 million and have equity requirements that range from $10 million to $500 million. It does not invest in startups or early stage businesses.
Stockton Road Managing Partner Joe Rhodes said in a statement about the investment, "We are honored to be able to work with truly world-class organizations like Jamieson and CCMP."
As part of the transaction, Stockton Road Operating Partner Cyrill Siewert will be joining the Board of Directors of Jamieson Laboratories, the biggest manufacturer and distributor of natural health products in Canada. It is also engaged in the development of proprietary supplement formulas. The company has state of the art laboratories in Windsor, Ontario and holds corporate headquarters in Toronto. Its products are exported in more than 50 countries.
Siewert said in the statement, "Jamieson is an iconic brand in the consumer health and wellness space with great growth potential not only in Canada, but around the globe. We look forward to supporting this growth."
This is not the first investment that Stockton Road has made in the nutrition sector. Their other investments in the space include Amerifit Brands and Culturelle, Airborne, Designer Protein, Maximum Human Performance and Select Nutrition.
According to the statement, Jamieson's investment banking advisor was William Hood of Houlihan Lokey.
CCMP Capital Advisors is focused on middle market buyouts and growth equity investments ranging from $100 million to $500 million in North America and Europe. It makes investments in the consumer, industrial, energy and healthcare industries.
Join the Conversation